Optimization of competitively differentiated polymerase chain reaction in detection of HBV basal core promoter mutation
- PMID: 15962387
- PMCID: PMC4315973
- DOI: 10.3748/wjg.v11.i23.3614
Optimization of competitively differentiated polymerase chain reaction in detection of HBV basal core promoter mutation
Abstract
Aim: To improve competitively differentiated polymerase chain reaction (CD-PCR) in detection of HBV basal core promoter mutation.
Methods: Recombinant plasmid of double point mutation A1762T/G1764A in basal core promoter of HBV constructed by site-directed mutagenesis was used as mutant control. To reveal the deficiency mechanism of CD-PCR, relationship between the circle number of PCR and the increased speed of products of each competitive primer was comparatively studied. Diversified amount of dNTPs and mutual primer of the competitive primers were tried to optimize CD-PCR. Optimized CD-PCR was evaluated by detecting A1762T/G1764A mutation in recombinant plasmids and clinical sera from patients with HBV infection.
Results: The deficiency mechanism of CD-PCR was that the products of mismatched competitive primer grew fast when the amplification of matched primer entered into plateau stage, which led to decrease in or disappearance of the difference in the amount of their products. This phenomenon could be eliminated by reducing dNTPs to 10 micromol/L and mutual primer to about 100 nmol/L. Optimized CD-PCR could detect both mutant and wild strain independent of the amount of templates and the number of PCR cycles. Its detection limit was 10(3) copies/mL, about 50 copies/reaction. About 10% of mutant DNAs among wild type DNAs could be detected. A1762T/G1764A mutant was detected in 41.8% (51/122) of patients with HBV infection, but not detected in controls with negative HBsAg.
Conclusion: Optimized CD-PCR can detect mutation independent of the amount of initial templates and the number of PCR cycles.
Figures


Similar articles
-
Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus.World J Gastroenterol. 2003 Aug;9(8):1743-6. doi: 10.3748/wjg.v9.i8.1743. World J Gastroenterol. 2003. PMID: 12918112 Free PMC article.
-
Ultrasensitive quantification of hepatitis B virus A1762T/G1764A mutant by a SimpleProbe PCR using a wild-type-selective PCR blocker and a primer-blocker-probe partial-overlap approach.J Clin Microbiol. 2011 Jul;49(7):2440-8. doi: 10.1128/JCM.02472-10. Epub 2011 May 11. J Clin Microbiol. 2011. PMID: 21562108 Free PMC article.
-
Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients.Antiviral Res. 2012 Nov;96(2):108-14. doi: 10.1016/j.antiviral.2012.08.009. Epub 2012 Aug 31. Antiviral Res. 2012. PMID: 22960603
-
[HBV C gene mutation in the transmission from father to infant].Zhonghua Er Ke Za Zhi. 2003 Nov;41(11):845-8. Zhonghua Er Ke Za Zhi. 2003. PMID: 14728893 Chinese.
-
Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions.Acta Virol. 1996 Jun;40(3):133-8. Acta Virol. 1996. PMID: 8891092
References
-
- Liaw YF. Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat. 2002;9:393–399. - PubMed
-
- Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22:5093–5107. - PubMed
-
- Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med. 2004;350:1118–1129. - PubMed
-
- Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol. 2002;37:283–287. - PubMed
-
- He C, Nomura F, Itoga S, Isobe K, Nakai T. Prevalence of vaccine-induced escape mutants of hepatitis B virus in the adult population in China: a prospective study in 176 restaurant employees. J Gastroenterol Hepatol. 2001;16:1373–1377. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources